Incidence of Invasive Fungal Infections in Patients With Previously Untreated Acute Myeloid Leukemia Receiving Venetoclax and Azacitidine.

Zhang, Alexander; Johnson, Tanner; Abbott, Diana; Phupitakphol, Tanit; Gutman, Jonathan A; Pollyea, Daniel A; Koullias, Yiannis

Zhang, Alexander; Johnson, Tanner; Abbott, Diana; Phupitakphol, Tanit; Gutman, Jonathan A; Pollyea, Daniel A; Koullias, Yiannis.

Afiliación

Zhang A; School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA.
Johnson T; Department of Pharmacy, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA.
Abbott D; Department of Biostatistics and Informatics, Center for Innovative Design and Analysis, Colorado School of Public Health, Aurora, Colorado, USA.
Phupitakphol T; Division of Infectious Diseases, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA.
Gutman JA; Division of Hematology, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA.
Pollyea DA; Division of Hematology, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA.
Koullias Y; Division of Infectious Diseases, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA.

Open Forum Infect Dis ; 9(10): ofac486, 2022 Oct.

Article en En | MEDLINE | ID: mdl-36225746

Palabras clave

acute myeloid leukemia; azacitidine; invasive fungal infection; prophylaxis; venetoclax

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Open Forum Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google